Health-Related Quality of Life in Patients With Metastatic Basal Cell Carcinoma Treated With Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial. J of Skin 2024, 8 (1), s337. https://doi.org/10.25251/skin.8.supp.337.